Voleon Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.75M Buy
+253,311
New +$1.81M 0.07% 254
2026
Q2
– Sell
-74,700
Closed -$262K – 856
2026
Q1
$262K Sell
74,700
-555,557
-88% -$1.78M 0.01% 689
2025
Q4
$1.72M Buy
630,257
+490,288
+350% +$1.13M 0.04% 359
2025
Q3
$304K Sell
139,969
-369,699
-73% -$873K 0.01% 714
2025
Q2
$877K Buy
+509,668
New +$1.27M 0.05% 255

Other funds holding IOVA

Voleon Capital Management's IOVA Position: Q3 2026 in Review

Voleon Capital Management opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2026: 253,311 shares worth $3.75M. The stake represents 0.07% of the portfolio and ranks #254 among its holdings. This is a return to the name: Voleon Capital Management previously reported a position in IOVA as recently as Q1 2026.

Voleon Capital Management first reported a position in IOVA in Q2 2025 and has held it in 5 quarters since. 335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • Voleon Capital Management held 253,311 shares of Iovance Biotherapeutics worth $3.75M as of Q3 2026.
  • Iovance Biotherapeutics was a new Voleon Capital Management position in Q3 2026.
  • Iovance Biotherapeutics made up 0.07% of Voleon Capital Management's portfolio in Q3 2026, its #254 holding.
  • Voleon Capital Management first reported a position in Iovance Biotherapeutics in Q2 2025 and has held it in 5 quarters since.
  • 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on Voleon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.